会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Systems and methods of determining injection protocols for image diagnosis procedure
    • 用于图像诊断程序的确定注射方案的系统和方法
    • JP2013255811A
    • 2013-12-26
    • JP2013146563
    • 2013-07-12
    • Medrad Incメドラッド インコーポレーテッドMedrad,Inc.
    • KALAFUT JOHN FUBER ARTHUR E
    • A61B6/03A61B5/055A61B6/00A61B8/00A61M5/00
    • A61M5/007A61B5/0044A61B5/02028A61B5/0205A61B5/026A61B5/029A61B5/0295A61B5/055A61B5/7257A61B6/032A61B6/481A61B6/504A61B6/507A61B6/583A61B8/13A61B8/481A61K49/0002G01R33/5601G06F19/321G06F19/3468G16H50/50
    • PROBLEM TO BE SOLVED: To provide methods for adjusting injection protocols with respect to each individual patient.SOLUTION: A step is included for specifying a patient transfer function based on data specific to the patient, wherein the patient transfer function predicts enhancement at desired level, which is output from one or more regions of interest in an individual patient, in response to a predetermined input. A step is included in which, when a fluid containing a contrast-enhancing fluid is diffused, by using scanning data obtained by test-scanning the one or more regions of interest, the output of the enhancement level due to the diffusion of the fluid is determined in synchronization at a plurality of points from each of the one or more regions of interest. By using at least several operation data obtained through the test scanning, the patient transfer function is updated, and a predetermined input is determined through a numerical optimization technique. Injection protocols for individual patient is determined when the predetermined input is input in the patient transfer function, thereby generating the enhancement at desired level in the one or more regions of interest. It is preferable that the injection protocols are managed in relation to diagnostic imaging procedure.
    • 要解决的问题:提供相对于每个单独患者调整注射方案的方法。解决方案:包括用于根据患者特异性的数据指定患者转移功能的步骤,其中患者转移功能预测在所需水平的增强, 其响应于预定输入,从单个患者中的一个或多个感兴趣区域输出。 包括其中当包含对比度增强液体的流体扩散时,通过使用通过对一个或多个感兴趣区域进行测试扫描获得的扫描数据,由于流体的扩散而导致的增强水平的输出是 在来自所述一个或多个感兴趣区域中的每一个的多个点上同步地确定。 通过使用通过测试扫描获得的至少几个操作数据,更新患者传递功能,并且通过数字优化技术确定预定输入。 在患者转移功能中输入预定输入时确定个体患者的注射方案,从而在一个或多个感兴趣区域中产生所需水平的增强。 优选地,针对诊断成像过程管理注射方案。
    • 2. 发明专利
    • PERSONAL DOSIMETER HAVING GAS VOLUME SECTION ON INTEGRATED CIRCUIT
    • JPS6463887A
    • 1989-03-09
    • JP822288
    • 1988-01-18
    • MEDRAD INC
    • AASAA II UUBAA ZA SAADO
    • H01L31/09G01T1/00G01T1/185G01T1/24G01T7/12H01J47/02
    • PURPOSE: To provide a personal dose meter which is reduced in size and weight and can accurately measure the total dose and dosage rate of the user by providing the collecting electrodes of ion chambers directly one integrated circuits and compensating the leakage currents between the drains of switching transistors and integrated circuit boards. CONSTITUTION: Ion chambers 16 are formed by defining gas volume sections with semispheric tissue equivalent plastic valves and providing the sections on collecting electrodes incorporated in integrated circuits. Signals from the collecting electrodes are sent to amplifiers 20 and further sent to leakage compensating/discharge controllers 22 in an detector control/interface unit 14. In addition, the value detected by means of a dose/dosage rate calculating and control device 30 is stored in a memory 32 and connected to an operator interface 34 and an electronic interface 36. The interface 34 is provided with an alarm circuit 33. The interfaces and circuits are formed as single or a plurality of ICs. Therefore, the size and weight of a personal dose meter can be reduced and the dose meter can accurately measure the dose/dosage rate of the user.
    • 3. 发明专利
    • A device and method for determining activity of radiopharmaceutical agent
    • 用于确定放射性核素的活性的装置和方法
    • JP2013011441A
    • 2013-01-17
    • JP2010277820
    • 2010-12-14
    • Medrad Incメドラッド インコーポレーテッドMedrad,Inc.
    • CHAD E BOUTONARTHUR E UBER III
    • G01T1/167G01T1/161G01T7/00
    • G01T7/02A61M5/007
    • PROBLEM TO BE SOLVED: To measure a radioactive agent using a detector system.SOLUTION: A fluid path receives at least one aliquot of a radiopharmaceutical. The fluid path locates the aliquot within a positioner formed to have a concave configuration. A detector is located at a certain axial distance from the concave surface and determines the level of radioactivity of the aliquot. Alternatively, the fluid path may be free of concave and a variable attenuator may be placed between the fluid path and the detector. The variable attenuator may have a concavity that is based on the concavity of the fluid path so that the detector's ability to read the radioactivity is optimized. A method for forming an aliquot of a radiopharmaceutical in a concave fluid passage includes arranging a detector to a position separated from the concave surface by a certain distance to optimize reading of spectral energy emitted from the aliquot and activity and determine radioactivity regardless of the position of the aliquot in the passage.
    • 要解决的问题:使用检测器系统测量放射性试剂。 解决方案:流体通道接收放射性药物的至少一个等分试样。 流体路径将等分试样定位在形成为具有凹形构型的定位器内。 检测器位于距离凹面一定轴向距离处,并确定等分试样的放射性水平。 或者,流体路径可以没有凹陷,并且可变衰减器可以被放置在流体路径和检测器之间。 可变衰减器可以具有基于流体路径的凹部的凹度,使得检测器读取放射性的能力被优化。 在凹形流体通道中形成放射性药物的等分试样的方法包括将检测器布置在与凹面相隔一定距离的位置,以优化从等分试样和活性发射的光谱能量的读数,并确定放射性,而不管 通道中的等分试样。 版权所有(C)2013,JPO&INPIT
    • 6. 发明专利
    • Syringe assembly, method for forming syringe assembly, and adapter for forming syringe assembly
    • 注射器组件,形成SYRINGE组件的方法和用于形成SYRINGE组装的适配器
    • JP2011224273A
    • 2011-11-10
    • JP2010099351
    • 2010-04-23
    • Medrad Incメドラッド インコーポレーテッドMedrad,Inc.
    • LISCIO EDWARD PCASTILLO LUISMCNEIL MICHAELHITCHINS MARK W
    • A61M5/142A61M5/145
    • PROBLEM TO BE SOLVED: To provide a syringe assembly, a syringe interface used having various types of syringe assembly, and an adapter.SOLUTION: The syringe assembly connectable to an injector having a syringe interface and a driving member includes a barrel portion 110a containing a fluid to be pressurized, and a syringe portion 100a having an exit 132a connected to the barrel portion 110a so as to allow a fluid to flow to the barrel portion 110a and flow back therefrom. The syringe assembly is formed separately from the syringe portion 100a. and includes an adapter 200 that has a plurality of portions. The syringe assembly includes an attaching mechanism having only two portions that engage so that the adapter 200 is immovably connected to the syringe portion 100a, the adapter 200 being configured so as to be connectable to the injector syringe interface.
    • 要解决的问题:提供一种注射器组件,使用具有各种类型的注射器组件的注射器接口和适配器。 解决方案:可连接到具有注射器接口和驱动构件的注射器的注射器组件包括容纳待加压流体的筒部110a和具有连接到筒部110a的出口132a的注射器部分100a,以便 允许流体流到筒部110a并从其流出。 注射器组件与注射器部分100a分开形成。 并且包括具有多个部分的适配器200。 注射器组件包括仅具有接合的两个部分的连接机构,使得适配器200不可移动地连接到注射器部分100a,适配器200构造成可连接到注射器注射器接口。 版权所有(C)2012,JPO&INPIT
    • 7. 发明专利
    • Device, system and method for determining parameters of one or more phases of injection procedure
    • 用于确定一个或多个注射步骤参数的装置,系统和方法
    • JP2011147796A
    • 2011-08-04
    • JP2011048581
    • 2011-03-07
    • Medrad Incメドラッド インコーポレーテッドMedrad,Inc.
    • KALAFUT JOHN FMISHLER DAVID A
    • A61M5/00A61M5/142
    • A61M5/007A61B6/507A61M5/14546A61M5/16854A61M2005/14208A61M2205/3334A61M2205/50A61M2230/04G16H40/63
    • PROBLEM TO BE SOLVED: To provide devices, systems and methods for delivery of a pharmaceutical fluid to a patient, and, especially for delivery of a contrast medium to a patient during a medical injection procedure.
      SOLUTION: A fluid injection apparatus includes at least one pressurizing mechanism and at least a first fluid container (for example, syringe or a bulk container) operably associated with the at least one pressurizing mechanism. The first fluid container is adapted to contain a first fluid to be injected. The fluid injection apparatus also includes a controller operably associated with the at least one pressurizing mechanism. The controller includes a programming system to allow programming of an injection protocol including, for example, a plurality of phases. At least one parameter generator determines parameters of at least one of the plurality of phases based at least in part upon the injection procedure.
      COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供用于将药物流体递送到患者的装置,系统和方法,特别是在医疗注射程序期间将造影剂输送给患者。 解决方案:流体注射装置包括至少一个加压机构和至少一个可操作地与至少一个加压机构相关联的第一流体容器(例如,注射器或散装容器)。 第一流体容器适于容纳要注入的第一流体。 流体注射装置还包括可操作地与至少一个加压机构相关联的控制器。 控制器包括编程系统,以允许对包括例如多个相位的注入协议进行编程。 至少一个参数发生器至少部分地基于注射过程来确定多个相中的至少一个的参数。 版权所有(C)2011,JPO&INPIT
    • 8. 发明专利
    • Lesion plotting method and lesion plotting system
    • LESION绘图方法和LESION绘图系统
    • JP2006141497A
    • 2006-06-08
    • JP2004332756
    • 2004-11-17
    • Medrad Incメドラッド インコーポレーテッドMedrad,Inc.
    • KAWAMOTO YASUSHI
    • A61B6/03
    • A61B6/481A61M5/007
    • PROBLEM TO BE SOLVED: To provide a more appropriate imaging effect by providing an injection condition required for obtaining a desired imaging effect.
      SOLUTION: A lesion plotting method includes the steps of: injecting a small amount of a contrast agent from a syringe 8 only for time Tn and measuring a change in the blood concentration of the contrast agent by using an imaging apparatus 2; adding data based on the change in the blood concentration of the contrast agent at the time Tn over the time Tc required for injecting the contrast agent for an amount required for diagnosing and predicting the imaging effect for the injection required time Tc; and displaying the predicted imaging effect and urging to decide whether or not to change the injection condition of the contrast agent.
      COPYRIGHT: (C)2006,JPO&NCIPI
    • 要解决的问题:通过提供获得期望的成像效果所需的注射条件来提供更合适的成像效果。 解决方案:病变绘图方法包括以下步骤:仅从时间Tn从注射器8注入少量的造影剂,并通过使用成像装置2测量造影剂的血液浓度的变化; 基于在注射造影剂所需的时间Tc以上的时间Tn处的造影剂的血液浓度的变化的数据,用于诊断和预测注射所需时间Tc的成像效果所需的量; 并显示预测的成像效果并促使判定是否改变造影剂的注射状态。 版权所有(C)2006,JPO&NCIPI